Lara Sullivan is a seasoned executive in the biopharmaceutical industry. She has a proven track record of leading and growing companies in the oncology sector. As the President and CEO of Pyxis Oncology Inc, she has been instrumental in the company's growth and development.
Pyxis Oncology Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the lives of patients with cancer. The company's unique approach to cancer treatment involves leveraging the body's immune system to fight cancer cells. Pyxis Oncology Inc is committed to bringing innovative treatments to patients who need them the most.
Over the past year, the insider has sold a total of 27,917 shares and purchased 0 shares. This trend of selling shares is not uncommon among insiders, especially when the company's stock is performing well. However, it's important to note that insider selling does not necessarily indicate a negative outlook for the company.
https://finance.yahoo.com/news/insider-sell-president-ceo-lara-210324518.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.